Fmoc-Lys(Tfa)-OH,
76265-69-5,
Fmoc-N-epsilon-trifluoroacetyl-L-lysine,
MFCD00153360,
AK-44091,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-trifluoracetyl-L-lysine,
N|A-Fmoc-N|A-trifluoroacetyl-L-lysine,
fmoc-lys(-tfa)-oh,
Fmoc-L-Lys(tfa)-OH,
AC1Q71CY,
AC1Q71CZ,
SCHEMBL178772,
DTXSID00583803,
C23H23F3N2O5,
CF-483,
ZINC34781584,
AKOS015909869,
AC-8598,
CS-W011546,
FCH4042803,
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-(2,2,2-trifluoroacetamido)hexanoic acid,
KS-0000118P,
AJ-90172,
AS-14205,
K305,
AB0014154,
AX8022525,
Fmoc-Lys(Tfa)-OH, >=96.0% (HPLC),
FT-0081956,
FT-0651238,
ST24047291,
M-1005,
265F695,
I14-3202,
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[(2,2,2-trifluoroacetyl)amino]hexanoic acid,
N~2~-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-N~6~-(trifluoroacetyl)-L-lysine,
N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-(2,2,2-trifluoroacetyl)-L-lysine,
ACN-033377,
Fmoc-Lys(Tfa)-OH, 98% - 1G 1g,
A7931,
N-alpha-Fmoc-N-epsilon-tritfluoroacetyl-L-lysine,